Idea Week Unveils Performer

Posted: Updated:
Michael Carbonaro will bring his live show to South Bend for Idea Week. Michael Carbonaro will bring his live show to South Bend for Idea Week.

Idea Week, hosted by the University of Notre Dame's IDEA Center, the South Bend-Elkhart Regional Partnership and various community organizations, says magician Michael Carbonaro will perform April 9 as part of the week-long festivities. Carbonaro is the second act unveiled, following the announcement that Tim McGraw will play to a sold-out audience at the Joyce Center April 13.

Carbonaro is the headliner of truTV’s hit show “The Carbonaro Effect” and will bring his live show to Idea Week, an annual event celebrating innovation, entrepreneurs and new ideas.

This year’s event will offer than 50 sessions broken up into four categories: Learn, Play, Meet and Compete.

Keynote speakers will include Bill Nye and Wired Magazine co-founder Kevin Kelly. “Idea Week is an innovation festival,” Event Director Nick Swisher said in a news release. “While world-renowned speakers like Bill Nye and Kevin Kelly will represent the learning side of Idea Week, acts like Carbonaro and Tim McGraw will represent the fun and celebration side.”

Tickets to see Carbonaro range from $35 to $160 and go on sale February 8.

For more information, click here.  

  • Perspectives

    • Owe Taxes? What Went Wrong in 2018 and How to Survive It

      The 2018 tax filing deadline came and went. Whew! But for some Americans, the tax headache has just begun. This year was the first filing under the Tax Cuts and Jobs Act and while some taxpayers saw larger refunds others received a rude awakening. If you’re reeling from a large tax burden, this article is for you. The Root of the Problem Remember how excited you were when you received your first paycheck—followed by dismay when you saw how much was taken out for taxes.



Company Name:
Confirm Email:
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections


  • Most Popular Stories

    • Photo of Gary City Hall courtesy of the City of Gary

      McDermott Details Gary Retail Desert

      The city of Gary is facing challenges as it tries to rejuvenate retail business in the city. In an interview with our partners at The Times of Northwest Indiana, Aaron McDermott, president of Latitude Commercial Real Estate Services in Schererville, says the challenge is due to the perception, proximity and demographics associated with Gary. 

    • The Landing project involves redeveloping seven buildings and two parking lots into a mixed-use development.

      New Restaurant Concept Coming to The Landing

      The developers of a $34 million redevelopment project in downtown Fort Wayne have announced a new partnership. Cincinnati-based The Model Group says it is working with Cunningham Restaurant Group to bring a "new and unique" restaurant experience to The Landing.

    • Ball State Among '30 Best Online MBA Degree Programs'

      Ball State University’s Miller College of Business has been recognized as one of The 30 Best Online MBA Degree Programs by MBA Central. The website details 30 programs across the nation and praises Ball State’s program for its variety and affordability.

    • Ryan Wagoner

      Profit With a Purpose: The Rise of Social Impact Investing

      Social impact investing is a fast-growing sector driven by investors who want to use private capital to further the public good. This industry provides a unique opportunity for results-oriented social entrepreneurs to invest in businesses, funds and nonprofits with the intention of generating positive, measurable social change alongside financial return. By engaging in impact investing, investors can align their investment portfolios with their philanthropic priorities.

    • Lilly and Avidity Biosciences Announce Partnership

      Indianapolis-based Eli Lilly and Co. (NYSE: LLY) and Avidity Biosciences Inc. have announced a new partnership. The global licensing and research collaboration will work toward the discovery, development and commercialization of new medicines in immunology and other areas.